Cover Image

Tumor molecular profiling of responders and non-responders following pembrolizumab monotherapy in chemotherapy resistant advanced cervical cancer

Optimal treatment for advanced cervical cancer after first line chemotherapy remains undefined. Immune checkpoint inhibition with pembrolizumab, a programmed cell death protein 1(PD-1) inhibitor, is under investigation. We analyzed the micro-environmental and molecular genetic profile of tumors from...

Full description

Saved in:
Bibliographic Details
Main Authors: N.Y.L. Ngoi (Author), V. Heong (Author), X.W. Lee (Author), Y.Q. Huang (Author), Y.L. Thian (Author), B.A. Choo (Author), D. Lim (Author), Y.W. Lim (Author), S.E. Lim (Author), A. Ilancheran (Author), R. Soong (Author), D.S.P. Tan (Author)
Format: Book
Published: Elsevier, 2018-05-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items